Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

GDT

Guidant (GDT)

Guidant Corp
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:GDT
DateHeureSourceTitreSymboleSociété
21/04/200619h02PR Newswire (US)Boston Scientific Completes Combination with GuidantNYSE:GDTGuidant Corp
21/04/200615h12PR Newswire (US)Abbott Completes Acquisition of Guidant Vascular BusinessNYSE:GDTGuidant Corp
20/04/200615h00PR Newswire (US)Boston Scientific Receives FTC Antitrust Approval for its Combination with GuidantNYSE:GDTGuidant Corp
12/04/200601h05PR Newswire (US)Standard & Poor's Announces Changes to U.S. IndicesNYSE:GDTGuidant Corp
11/04/200619h59PR Newswire (US)Boston Scientific Receives European Commission's Antitrust Clearance for Guidant TransactionNYSE:GDTGuidant Corp
05/04/200623h34PR Newswire (US)Boston Scientific Signs Agreement Resolving All Outstanding Antitrust Issues With FTC Staff on Guidant TransactionNYSE:GDTGuidant Corp
05/04/200623h25Business WireGuidant Announces Preliminary First Quarter 2006 SalesNYSE:GDTGuidant Corp
31/03/200619h03PR Newswire (US)Boston Scientific and Guidant Shareholders Each Approve CombinationNYSE:GDTGuidant Corp
29/03/200615h00Business WireGuidant to Temporarily Suspend XIENCE V Supply; Company Expects European Launch of XIENCE V in Third Quarter 2006NYSE:GDTGuidant Corp
24/03/200600h10PR Newswire (US)Boston Scientific Makes Antitrust Commitments To European CommissionNYSE:GDTGuidant Corp
21/03/200613h30Business WireGuidant Receives Independent Panel Report and Recommendations; Panel Chaired by Dr. Myerburg, an Internationally Recognized LeaNYSE:GDTGuidant Corp
21/03/200613h25PR Newswire (US)Independent Panel Commissioned by Guidant Issues Report and RecommendationsNYSE:GDTGuidant Corp
20/03/200615h30PR Newswire (US)Institutional Shareholder Services Recommends That Shareholders of Boston Scientific and Guidant Approve CombinationNYSE:GDTGuidant Corp
17/03/200615h00Business WireGuidant Announces Enrollment of First Patient in Landmark Carotid Artery Stenting Study; 10,000-Patient Study Aims to Further UNYSE:GDTGuidant Corp
16/03/200620h30Business WireGuidant to Expand Southern California Facilities; Drug Eluting and Carotid Stents, Emerging Therapies Drive ExpansionNYSE:GDTGuidant Corp
15/03/200620h29Business WireGuidant Completes Enrollment in Randomized U.S. Portion of Drug Eluting Stent Pivotal Trial; Large-Scale Trial Evaluating SafetNYSE:GDTGuidant Corp
14/03/200621h58Business WireGuidant Announces Updated and Positive Results of Real-World Carotid Artery Stenting Study; Results from 2,500 Patients SuggestNYSE:GDTGuidant Corp
13/03/200615h00Business WireGuidant Initiates Voluntary Worldwide Physician Communication Regarding Implantable Cardiac DefibrillatorsNYSE:GDTGuidant Corp
10/03/200619h00Business WireR. Frederick McCoy, Jr., Elects Early Retirement from GuidantNYSE:GDTGuidant Corp
09/03/200618h00Business WireGuidant Launches Innovative Cobalt Chromium Biliary Stent; RX HERCULINK ELITE Biliary Stent System Provides Superb DeliverabiliNYSE:GDTGuidant Corp
09/03/200615h02Business WireGuidant Announces Enrollment of First Patient in Clinical Trial of the World's First Fully Bioabsorbable Drug Eluting CoronaryNYSE:GDTGuidant Corp
06/03/200617h14PR Newswire (US)Seven Summits Research Releases Comments on GM, RIMM, CELG, GDT, and LEXRNYSE:GDTGuidant Corp
03/03/200600h11PR Newswire (US)Boston Scientific and Guidant Proposed Merger Registration Statement Declared EffectiveNYSE:GDTGuidant Corp
23/02/200618h09PR Newswire (US)Boston Scientific Files Notification with European CommissionNYSE:GDTGuidant Corp
23/02/200614h31Business WireGuidant Announces Completion of FDA Inspection of St. Paul Facilities; Company Reports One Inspection Observation and ReiteratesNYSE:GDTGuidant Corp
07/02/200614h00Business WireTheregen Announces Equity Investment from Guidant Corporation to Develop Anginera(TM) Epicardial PatchNYSE:GDTGuidant Corp
06/02/200616h32PR Newswire (US)Boston Scientific Files Hart-Scott-Rodino Pre-Merger NotificationNYSE:GDTGuidant Corp
30/01/200620h02Business WireGuidant Receives European Approval for Drug Eluting Coronary Stent; Company Achieves CE Mark Approval Ahead of Schedule; XIENCENYSE:GDTGuidant Corp
27/01/200614h30Business WireGuidant Reports Fourth Quarter Sales of $828 Million; Full Year 2005 Sales of $3.55 Billion; Earnings from Continuing OperationsNYSE:GDTGuidant Corp
25/01/200613h02PR Newswire (US)Boston Scientific and Guidant Announce Signing of Merger Agreement Valued at $27 BillionNYSE:GDTGuidant Corp
 Showing the most relevant articles for your search:NYSE:GDT